Effects of locally administered argatroban on restenosis after balloon angioplasty: Experimental and clinical study

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 11, 1997, Pages 800-806

  Imanishi, Toshio ^a,b   Arita, Mikio ^a   Tomobuchi, Yoshiaki ^a   Hamada, Masanori ^a   Hano, Takuzo ^a   Nishio, Ichiro ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Argatroban; Hydrogel coated balloon catheter; Restenosis

Indexed keywords

ARGATROBAN; CARBON 14; CELL NUCLEUS ANTIGEN; THROMBOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG TISSUE LEVEL; FLUORESCENCE; HYDROGEL; IMMUNOHISTOCHEMISTRY; INTRAARTERIAL DRUG ADMINISTRATION; ISOTOPE LABELING; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RABBIT; RESTENOSIS; THROMBOCYTE ADHESION;

EID: 0030874820     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb02694.x     Document Type: Article

References (39)

1. Nobuyoshi M, Kimura T, Nosaka H et al. Restenosis after successful transluminal coronary angioplasty: Serial angiographic follow-up of 220 patients. J. Am. Coll. Cardiol. 1988; 12: 616-23.
2. Serrys PW, Luijiten HE, Beatt KJ et al. Incidence of restenosis after successful coronary angioplasty: A time phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2 and 3 months. Circulation 1988; 77: 361-72.
3. Casscells W. Migration of smooth muscle and endothelial cells: Critical events in restenosis. Circulation 1993; 86: 723-9.
4. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies. J. Am. Coll. Cardiol. 1991; 17: 758-69.
5. Annex BH, Denning SM, Channon KM et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-22.
6. Nemerson Y. Tissue factor and hemostasis. Blood 1988; 77: 361-72.
7. Vu T-K, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
8. Nelken NA, Soifer SJ, O'Keefe J, Vu T-K, Charo IF, Couglin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J. Clin. Invest. 1992; 90: 1614-21.
9. Wilcox JN, Rodriguez J, Subrammanian R et al. Characterization of thrombin receptor expression during vascular lesion formation. Circ. Res. 1994; 75: 1029-38.
10. Hatton MW, Moar SL, Richardson M. De-endotherization in vivo initiates a thrombogenic reaction at the rabbit aorta surface: Correlation of uptake of fibrinogen and antithrombin III with thromhin generation by the exposed subendothelium. Am. J. Pathol. 1989; 135: 499-508.
11. Okamoto S, Hijikata A. Potent inhibition of thrombin by the newly synthesized argatroban derivative no. 805: The importance of stereostructure of its hydrophobic carboxamide portion. Biochem. Biophys. Res. Commun. 1981; 101: 440-6.
12. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hefti F, Hosang M. Inhibition of angiotensin-converting enzyme prevents myointimal proliferation after vascular injury. Science 1989; 245: 186-8.
13. Toshio I, Mikio A, Masanori H, Yoshiaki T, Takuzo H, Ichiro N. Effects of locally administered argatroban using hydrogel-coated balloon catheter on intimal thickening induced by balloon injury. Jpn Circ. J. 1997; 61: 256-62.
14. Wolinsky H, Thung SN. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J. Am. Coll. Cardiol. 1990; 15: 475-81.
15. Nunes GL, Hanson SR, King SB III, Sahatjian RA, Scott NA. Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. J. Am. Coll. Cardiol. 1994; 23: 1578-83.
16. Riessen R, Rahimidadeh H, Blessing E, Takeshita S, Barry JJ, Isner JM. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum. Gene Ther. 1993; 4: 749-58.
17. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): Structural observation and detection of a nucleolar form. J. Cell. Sci. 1990; 96: 121-7.
18. Prelich G, Stillman B. Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell 1988; 53: 117-26.
19. Cartun RW, Pederson CA. An immunocytochemical technique offering increased sensitive and lower cost utilizing a streptavidin-horseradish peroxidase conjugate. J. Histochem. 1989; 12: 273-7.
20. Sarembock IJ, Gertz SD, Gimple LW. Owen RM, Powers ER, Roberts WC. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1991; 84: 232-43.
21. Topol EJ, Califf RM, Weisman HF et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 1994; 343: 881-6.
22. Bar-Shavitt R, Eldor A, Vlodavsky I. Binding of thrombin to subendothelial extracellular matrix: Protection and expression of functional properties. J. Clin. Invest. 1989; 84: 1096-104.
23. Chesebro JH, Lodohelyi P, Fuster V. Pathogenesis of thrombosis in unstable angina. Am. J. Cardiol. 1991; 68: B2-10.
24. Harker LA. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am. J. Cardiol. 1987; 60: B20-8.
25. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: Time course and relation to vascular injury. Circulation 1987; 75: 636-42.
26. Weitz JI, Hudosa M, Mussel D, Maraganore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III independent inhibitors. J Clin. Invest. 1990; 86: 385-91.
27. Wilner GD, Danitz MP, Susan Mudo M, Heieh KH, Fenton JW II. Selective immobilization of alpha-thrombin by surface-bound fibrin. J. Lab. Clin. Med. 1981; 180: 403-11.
28. McNamara CA, Sarembock IJ, Gimple LW, Fenton JWL, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 1993; 91: 94-8.
29. Pasche B, Swedenborg J, Hedin U, Olsson P, Ljungquist A. Thrombin-inhibitory capacity of the injured vessel wall. Thromb. Res. 1991; 62: 531-4.
30. Meyer BJ, Ferandez-Oriz A, Malihac A et al. Local delivery of r-hirudin by a double-balloon perforation catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Circulation 1994; 90: 2474-80.
31. Hillegass WB, Ohman EM, Califf RM, Restenosis: The clinical issues. In: Topol EJ (ed.). Textbook of International Cardiology, 2nd edn. WB Saunders Co., Philadelphia. 1993; 415-35.
32. Cannon CP, McCabe CH, Henry TD et al. A pilot trial in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction (TIMI) 5 trial. J. Am. Coll. Cardiol. 1994; 23: 993-1003.
33. Chobanian AV, Haudenschild CC, Nickerison C, Drago R. Antiatherogenic effect of captopril in Watanabe heritable hyperlipidemic rabbit. Hypertension 1990; 15: 327-31.
34. Lam JTY, Lacoste L, Bourassa MG. Cilazapril and early atherosclerotic changes after balloon injury to porcine carotid arteries. Circulation 1992; 85: 1542-7.
35. Azrin MA, Mitchel JF, Fram DB et al. Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloon. Circulation 1994; 90: 433-41.
36. Steele PM, Chesebro JH, Stanson AW et al. Balloon angioplasty: Natural history of the pathophysiologic response to injury in a pig model. Circ. Res. 1985; 57: 105-12.
37. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury, IV: Heparin inhibits rat smooth muscle mitogenesis and migration. Circ. Res. 1986; 58: 839-45.
38. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ. Res. 1990; 67: 651-9.
39. Zyemer U, Fishbein MC, Forrester JS, Cercek B. Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation: Compared with thymidine and bromodeoxyuridine labeling. Am. J. Pathol. 1992; 141: 685-90.